Cargando…

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.

Detalles Bibliográficos
Autores principales: Ortaboz, Damla, Çetin, Mehmed Semih, Cömert, Burak, Eşkazan, Ahmet Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937804/
https://www.ncbi.nlm.nih.gov/pubmed/36737174
http://dx.doi.org/10.1016/j.tranon.2023.101620
_version_ 1784890504123514880
author Ortaboz, Damla
Çetin, Mehmed Semih
Cömert, Burak
Eşkazan, Ahmet Emre
author_facet Ortaboz, Damla
Çetin, Mehmed Semih
Cömert, Burak
Eşkazan, Ahmet Emre
author_sort Ortaboz, Damla
collection PubMed
description
format Online
Article
Text
id pubmed-9937804
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-99378042023-02-19 ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al. Ortaboz, Damla Çetin, Mehmed Semih Cömert, Burak Eşkazan, Ahmet Emre Transl Oncol Commentary Neoplasia Press 2023-01-10 /pmc/articles/PMC9937804/ /pubmed/36737174 http://dx.doi.org/10.1016/j.tranon.2023.101620 Text en © 2023 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Ortaboz, Damla
Çetin, Mehmed Semih
Cömert, Burak
Eşkazan, Ahmet Emre
ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
title ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
title_full ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
title_fullStr ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
title_full_unstemmed ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
title_short ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
title_sort atra+ato combination in apl – a commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: a real-world analysis of 1105 patients over the last three decades” by teng-fei et al.
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937804/
https://www.ncbi.nlm.nih.gov/pubmed/36737174
http://dx.doi.org/10.1016/j.tranon.2023.101620
work_keys_str_mv AT ortabozdamla atraatocombinationinaplacommentaryonevolvingoftreatmentparadigmsandchallengesinacutepromyelocyticleukaemiaarealworldanalysisof1105patientsoverthelastthreedecadesbytengfeietal
AT cetinmehmedsemih atraatocombinationinaplacommentaryonevolvingoftreatmentparadigmsandchallengesinacutepromyelocyticleukaemiaarealworldanalysisof1105patientsoverthelastthreedecadesbytengfeietal
AT comertburak atraatocombinationinaplacommentaryonevolvingoftreatmentparadigmsandchallengesinacutepromyelocyticleukaemiaarealworldanalysisof1105patientsoverthelastthreedecadesbytengfeietal
AT eskazanahmetemre atraatocombinationinaplacommentaryonevolvingoftreatmentparadigmsandchallengesinacutepromyelocyticleukaemiaarealworldanalysisof1105patientsoverthelastthreedecadesbytengfeietal